Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2Plasma cell 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 76Lymphoma 73Lymphoma, Non-Hodgkin 66Hodgkin Disease 53Leukemia 40Lymphoma, Large B-Cell, Diffuse 37Multiple Myeloma 35Myelodysplastic Syndromes 34Lymphoma, Mantle-Cell 33Leukemia, Myeloid, Acute 33Leukemia, Lymphocytic, Chronic, B-Cell 30Burkitt Lymphoma 30Lymphoma, Follicular 26Leukemia, Myelogenous, Chronic, BCR-ABL Positive 18Lymphoma, B-Cell, Marginal Zone 17Lymphoma, Large-Cell, Immunoblastic 15Recurrence 12Myeloproliferative Disorders 11Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 10Neoplasms, Plasma Cell 9Hematologic Neoplasms 9Dendritic Cell Sarcoma, Interdigitating 9Lymphoma, T-Cell 8Leukemia, Myelomonocytic, Chronic 8Leukemia, Biphenotypic, Acute 8Primary Myelofibrosis 7Leukemia, Myelomonocytic, Juvenile 7Blast Crisis 7Waldenstrom Macroglobulinemia 6Neoplasms 6

Interventions

Rituximab 12Cyclophosphamide 12fludarabine 8dacetuzumab 7blinatumomab 6Tacrolimus 6Busulfan 6Vincristine 5Prednisone 5Etoposide 5Doxorubicin 5Bortezomib 5fludarabine phosphate 4Valganciclovir 4Peripheral Blood Stem Cell Transplantation 4Mycophenolic Acid 4Epoetin Alfa 4venetoclax 3ibrutinib 3Whole-Body Irradiation 3Methotrexate 3Melphalan 3Lenalidomide 3Ganciclovir 3Everolimus 3Dexamethasone 3Darbepoetin alfa 3Alemtuzumab 3tetulomab tetraxetan lu-177 2ponatinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Lymphoproliferative Disorders × Granulocyte Colony-Stimulating Factor × Lymphoid × Clear all
NCT00092222 2026-06-05

Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity

National Institutes of Health Clinical Center (CC)

Phase 2 Active not recruiting
75 enrolled
Lymphoid

Multi-centric Castleman's Disease, Macular dystrophy, corneal type 1, Lymphadenopathy, Lymphoproliferative Disorders, Neoplasms, HIV Infections

NCT01186224 2025-03-17

PHANTASTIC

University of Liverpool

Phase NA Completed
60 enrolled
LymphoidPlasma cell

Lymphoma, Lymphoproliferative Disorders, Multiple Myeloma, Paraproteinemias

Data powered by HemOnc (CC BY 4.0) Colophon âš¡